Sean M. Devlin

19.4k total citations · 1 hit paper
269 papers, 4.0k citations indexed

About

Sean M. Devlin is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sean M. Devlin has authored 269 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Hematology, 75 papers in Oncology and 52 papers in Molecular Biology. Recurrent topics in Sean M. Devlin's work include Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (64 papers) and Multiple Myeloma Research and Treatments (49 papers). Sean M. Devlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (64 papers) and Multiple Myeloma Research and Treatments (49 papers). Sean M. Devlin collaborates with scholars based in United States, Spain and Italy. Sean M. Devlin's co-authors include Sergio Giralt, Martin S. Tallman, Miguel‐Angel Perales, Craig S. Sauter, Ola Landgren, Ross L. Levine, Maria E. Arcila, Ahmet Zehir, Molly Maloy and Parastoo B. Dahi and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Sean M. Devlin

244 papers receiving 4.0k citations

Hit Papers

Therapy-Related Clonal Hematopoiesis in Patients with Non... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
    2017 521 citations Sean M. Devlin, Martin S. Tallman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean M. Devlin United States 33 2.1k 1.6k 1.0k 770 624 269 4.0k
Pia Raanani Israel 35 1.6k 0.7× 878 0.6× 1.0k 1.0× 920 1.2× 673 1.1× 305 4.2k
Ronald Sobecks United States 29 2.2k 1.0× 1.2k 0.7× 669 0.6× 624 0.8× 592 0.9× 255 3.5k
Mahmoud Aljurf Saudi Arabia 36 2.3k 1.1× 1.2k 0.7× 609 0.6× 555 0.7× 633 1.0× 234 4.3k
Amer M. Zeidan United States 40 3.7k 1.7× 1.3k 0.8× 2.0k 1.9× 1.4k 1.8× 769 1.2× 407 5.6k
Mohamed A. Kharfan‐Dabaja United States 34 2.2k 1.0× 1.7k 1.1× 760 0.7× 882 1.1× 947 1.5× 313 4.5k
Edward A. Copelan United States 31 3.9k 1.8× 1.4k 0.9× 878 0.8× 933 1.2× 1.0k 1.6× 194 5.7k
Amin M. Alousi United States 34 2.5k 1.2× 902 0.6× 641 0.6× 569 0.7× 940 1.5× 244 3.7k
Vinod Pullarkat United States 38 3.8k 1.8× 1.2k 0.7× 1.9k 1.9× 1.4k 1.8× 865 1.4× 228 6.0k
Carlo Dufour Italy 38 2.9k 1.3× 1.2k 0.7× 1.1k 1.0× 871 1.1× 1.2k 1.9× 174 5.1k
Michel Delforge Belgium 31 2.6k 1.2× 1.6k 1.0× 2.1k 2.0× 646 0.8× 846 1.4× 150 4.4k

Countries citing papers authored by Sean M. Devlin

Since Specialization
Citations

This map shows the geographic impact of Sean M. Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean M. Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean M. Devlin more than expected).

Fields of papers citing papers by Sean M. Devlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean M. Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean M. Devlin. The network helps show where Sean M. Devlin may publish in the future.

Co-authorship network of co-authors of Sean M. Devlin

This figure shows the co-authorship network connecting the top 25 collaborators of Sean M. Devlin. A scholar is included among the top collaborators of Sean M. Devlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean M. Devlin. Sean M. Devlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landgren, Ola & Sean M. Devlin. (2024). Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A Roadmap. Blood Cancer Discovery. 6(1). 13–22. 3 indexed citations
2.
Stonestrom, Aaron J., Kamal Menghrajani, Sean M. Devlin, et al.. (2023). High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer. Blood Advances. 8(4). 846–856. 5 indexed citations
3.
Devlin, Sean M., Beatriz Wills, Amethyst Saldia, et al.. (2023). Comparison of Bendamustine Versus Fludarabine/ Cyclophosphamide Lymphodepletion in Adult Patients Receiving CD19 CAR-T Cell Therapy. Blood. 142(Supplement 1). 3510–3510. 1 indexed citations
4.
Nath, Karthik, Samantha Brown, Sean M. Devlin, et al.. (2023). Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(1). 81–92.
5.
Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2023). Gender disparities in allograft access due to HLA-sensitization in multiparous women. Blood Advances. 8(2). 403–406. 2 indexed citations
6.
Lin, Andrew, Samantha Brown, Molly Maloy, et al.. (2022). Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 63(7). 1686–1693. 2 indexed citations
7.
Scordo, Michael, Leah Gilbert, Jessica Flynn, et al.. (2022). Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Advances. 7(8). 1536–1544. 4 indexed citations
8.
Politikos, Ioannis, Carmen Lau, Sean M. Devlin, et al.. (2022). Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults. Blood Advances. 6(24). 6291–6300. 16 indexed citations
9.
Landau, Heather, Elizabeth Rodríguez, Allison J. Applebaum, et al.. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(12). 832.e1–832.e7. 5 indexed citations
10.
Devlin, Sean M. & Alexia Iasonos. (2022). Statistics in Oncology. Journal of Clinical Oncology. 40(30). 3471–3473.
11.
Lahoud, Oscar, Sean M. Devlin, Molly Maloy, et al.. (2021). Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation. Blood Advances. 5(14). 2879–2889. 18 indexed citations
12.
Tamari, Roni, Ioannis Politikos, David A. Knorr, et al.. (2021). Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy. Blood Cancer Discovery. 2(6). 577–585. 41 indexed citations
13.
Devlin, Sean M., Axel Martin, & Irina Ostrovnaya. (2021). Identifying prognostic pairwise relationships among bacterial species in microbiome studies. PLoS Computational Biology. 17(11). e1009501–e1009501. 1 indexed citations
14.
Devlin, Sean M. & Glenn Heller. (2020). Concordance probability as a meaningful contrast across disparate survival times. Statistical Methods in Medical Research. 30(3). 816–825. 4 indexed citations
15.
Menghrajani, Kamal, Sheng F. Cai, Sean M. Devlin, et al.. (2019). A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia. Blood. 134(Supplement_1). 2655–2655. 12 indexed citations
16.
Pianko, Matthew J., Sean M. Devlin, Eric R. Littmann, et al.. (2019). Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Advances. 3(13). 2040–2044. 47 indexed citations
17.
Goldberg, Aaron D., Chetasi Talati, Pinkal Desai, et al.. (2018). TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 1433–1433. 35 indexed citations
18.
19.
20.
Lendvai, Nikoletta, Patrick Hilden, Sean M. Devlin, et al.. (2014). A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. Blood. 124(6). 899–906. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pia Raanani Breakdown of academic impact, for papers by Ronald Sobecks Breakdown of academic impact, for papers by Mahmoud Aljurf Breakdown of academic impact, for papers by Amer M. Zeidan Breakdown of academic impact, for papers by Mohamed A. Kharfan‐Dabaja Breakdown of academic impact, for papers by Edward A. Copelan Breakdown of academic impact, for papers by Amin M. Alousi Breakdown of academic impact, for papers by Vinod Pullarkat Breakdown of academic impact, for papers by Carlo Dufour Breakdown of academic impact, for papers by Michel Delforge
Rankless by CCL
2026